key: cord-0726662-l1vyf8rk
authors: Hamet, Pavel; Pausova, Zdenka; Attaoua, Redha; Hishmih, Camil; Haloui, Mounsif; Shin, Jean; Paus, Tomas; Abrhamowicz, Michal; Gaudet, Daniel; Santucci, Lara; Kotchen, Theodore A; Cowley, Allen W; Hussin, Julie; Tremblay, Johanne
title: SARS-COV-2 RECEPTOR ACE2 GENE is associated with hypertension and SEVERity of COVID 19: interaction with sex, obesity and SMOKING
date: 2021-01-02
journal: Am J Hypertens
DOI: 10.1093/ajh/hpaa223
sha: 293c29b309b81e7339c7fbb2d04b126c67d3380f
doc_id: 726662
cord_uid: l1vyf8rk

BACKGROUND: ACE2 has been identified as the entry receptor for coronaviruses into human cells, including SARS-COV-2 that causes COVID-19. Since hypertension is a leading comorbidity in non-survivors of COVID-19, we tested for association between ACE2 gene and hypertension in interaction with specific pre-existing conditions known to be associated with COVID-19 severity. METHODS: Genetic analysis of ACE2 gene was conducted in French-Canadian and British populations. RESULTS: In French-Canadian individuals, the T allele of the single nucleotide polymorphism (SNP) rs2074192 of ACE2 gene was a risk factor for hypertension in adult obese males [odds ratio (OR)=1.39, 95% confidence interval (CI) 1.06-1.83)] and even more so in obese males who smoked (OR=1.67, CI: 1.24-2.55), but not in lean males, non-smoker males or females. The T allele was significantly associated with severity of hypertension and with earlier penetrance of hypertension in obese smoking males. Significant interaction between the T allele and obesity was present in both sexes. The association of ACE2 (rs233575) genotype with blood pressure was also seen in adolescents but the interaction with obesity was present only in females. Several variants in ACE2 gene were found to be associated with hypertension in obese, smoking males in British individuals of the UK Biobank. In addition, we observed more severe outcomes to COVID-19 in association with ACE2 risk alleles in obese, smoking males. CONCLUSION: This is the first report that ACE2 variants are associated with earlier penetrance and more severe hypertension and with more severe outcomes of COVID-19 in obese smoking males.

The severity of infection to coronaviruses including that of COVID-19 is known to be associated with age, sex and specific pre-existing conditions. 1, 2 Most mortality occurs in the elderly and is almost double in males (4.7%) compared to females (2.8%). Death rate of individuals with pre-existing conditions is nearly 10-fold higher than in individuals with no preexisting conditions. Similar to the 2003 SARS outbreak, hypertension preceding hospitalization was the most frequent comorbidity in non-survivors, in addition to diabetes and CVD, particularly in current smokers in COVID-19 cohorts. 3, 4 History of hypertension, smoking and obesity were also prevalent in COVID-19 hospitalized patients and non-survivors in the New-York city area. 5 The SARS coronaviruses, SARS-CoV and the new SARS-CoV-2, which causes COVID-19, bind to angiotensin converting enzyme 2 (ACE2). 3 

were initially studied in rodent models of hypertension 6 and human studies demonstrated genetic association with hypertension [7] [8] [9] and in individuals with CVD and type 2 diabetes 10, 11 .

Comparative mapping showed that Ace2 co-localizes with quantitative trait locus (QTL) for hypertension in stroke-prone hypertensive rats 12 and Sabra salt-sensitive rats 13 .

We reported previously an association between genetic variants in ACE2 with blood pressure in a cohort of adolescents, including the SNP rs2074192 located in intron 16 of ACE2 on chromosome X. 14 This SNP has been associated with blood pressure and hypertension in candidate-gene studies, yet was overlooked in most genome-wide association studies (GWAS) that typically do not analyze sex chromosomes.

Experimental and human studies of hypertension in the context of COVID-19 were the topic of a recent editorial comment. 15 A review documenting all genetic factors involved in Coronavirus host-susceptibility to infection and complications did not report any clear genetic association A c c e p t e d M a n u s c r i p t between ACE2 polymorphisms and susceptibility or severity to COVID-19 in the general population. 16 In the present study, we evaluated the possible associations between genetic polymorphisms of ACE2 with co-morbidities related to COVID-19. Our hypothesis is that hypertension, obesity and smoking act as effect modifiers of the impact of ACE2 in COVID-19 severity, that these effects may be age-and sex-variable.

We initially studied French-Canadian (FC) individuals recruited in the Saguenay-Lac-St-Jean area of the Canadian province of Quebec. This population is known for its Mendelian diseases caused by a founder effect due to fast demographic growth. 17, 18 Our sample consisted of multigenerational families, ascertained by the presence of an affected sibpair with hypertension and dyslipidemia, and with both parents of French-Canadian origin. 19 Since family information was not used here, we increased the number of hypertensive or normotensive individuals by including unrelated individuals. The sample size was 780 individuals. Hypertension (HT) was defined as having SBP or diastolic blood pressure (DBP) ≥140/90 mmHg on 2 occasions or currently taking anti-HT medication as in all our previous studies. 19, 20 . Our sample was divided into 2 categories: being able or not to withdraw anti-hypertensive medication. The latter group represented more severe hypertension, arrhythmias and participants with history of myocardial infarction.

ACE2 genotypes of rs2074192 were available for 352 males (59% hypertensive) and 428 females (61% hypertensive) from 122 families. A second randomly-selected sample from the A c c e p t e d M a n u s c r i p t Heart and Health Study (Santé du Coeur du Québec), from the same geographic region, consisted of 36 unrelated males (25% hypertensive) and 48 females (38% hypertensive) 21 . Smoking status was determined as either "ever smoker" or "never smoker", with "ever smoker" being a current regular or previous regular smoker. Obesity was defined as body mass index (BMI)  28 kg/m 2 according to FC study protocol 21 .

The third independent sample of French-Canadians was a sample of 525 adolescents (283 females and 242 males, age: 12-18 years, Table S2 ) from the Saguenay Youth Study (SYS), a population-based study aimed at investigating the etiology and early stages of common cardiometabolic and brain diseases. 22 The cohort was recruited via high schools. Both maternal and paternal grandparents were of French-Canadian ancestry born in the region. The adolescents studied here were those in whom rs233575 (see below) in ACE2 was genotyped and in whom blood pressure and body mass index (BMI) were measured. Due to the X-chromosome location of ACE2, all females who were heterozygotes for the genotype (n=153) were excluded from further study; the final sample size was 133 females (homozygotes) and 242 males.

Overweight/obesity was defined as BMI >=85 th age-and sex-specific percentile. 23 Puberty status was evaluated with a validated questionnaire. 24 Effect of cigarette smoking was not studied in this adolescent sample.

The UK Biobank population (mainly of White British origin) constituted our fourth sample where we also evaluated data from 17 606 individuals who had been tested for COVID19 and of which 1644 individuals were positive for COVID-19 infection. 25 

We genotyped SNP rs2074192 in intron 16 of ACE2 gene, known for its strongest association with hypertension [8] [9] [10] [11] 14 in 780 members of French-Canadian families and 85 unrelated subjects.

A 296 bp nucleotide fragment containing both SNPs was amplified by PCR using primers 5"GCCTTGCAACCTAGATTAGGT3" and 5"ATTGGCATTTGGAGGTAGCAC3", and 2 variants were revealed by the single-strand conformational polymorphism (SSCP) technique. In SYS adolescents, rs233575 in ACE2 was genotyped with the Human610-Quad BeadChips (Illumina, San Diego, CA). This SNP is located 176 bp apart from the SNP rs2074192, which was studied in 2 adult samples but not genotyped in SYS adolescents. Both

SNPs are in intron 16 of ACE2 ( Figure S1 ) and in partial LD (r 2 =0.37-0.47, D"=1 in various M a n u s c r i p t European subpopulations). Their genomic context was examined with ENCODE, 26 GTEx 27 and HaploReg. 28 (Figures S1 and S2 ).

Samples from the UK Biobank were genotyped with the UK BioBank Axiom arrays (Affymetrix, Santa Clara, California, USA). Genotype calling was performed by Affymetrix on two closely related purpose-designed arrays. ~50,000 participants were run on the UK BiLEVE Axiom array (Resource 149600) and the remaining ~450,000 were run on the UK Biobank Axiom array (Resource 149601). We analyzed 12 SNPs within ACE2 gene for their association with hypertension and severity to COVID-19 in the UK Biobank participants. They were selected from Disgenet database (https://www.disgenet.org/) for their association with CVD phenotypes. These SNPs were extracted from .bgen files using Plink2 software (https://www.cog-genomics.org/plink/2.0/). Linkage disequilibrium between SNPs was calculated by ld-estimator package (https://pypi.org/project/ld-estimator/) in Python ( Figure S5 ).

Descriptive statistics include means and standard deviations (SD) for continuous variables and proportions for categorical variables. Bivariate comparisons were made at the prespecified 2-sided alpha-level of 0.05, using Student"s t-test or the chi-square test, as appropriate.

All association analyses were performed separately for males and females. Differences in mean values of obesity measures between ACE2 allele T and C carriers were estimated by multiple linear regression, while the association of HT with ACE2, and its interactions with obesity and smoking, were analyzed using multiple logistic regression. In all regression analyses, the generalized estimating equations (GEE) approach was used to account for the dependence between individuals from the same family. 29 A c c e p t e d M a n u s c r i p t

Kaplan-Meier survival analyses were carried-out by kaplanmeier package (https://pypi.org/project/kaplanmeier/) in Python.

In the SYS adolescents, we used linear regression model to test whether ACE2 genotype (rs233575) is associated with systolic and diastolic blood pressures in interaction with sex and overweight/obesity. Both models were adjusted for age, puberty stage and height.

In the UK Biobank, odds-ratio (OR), standard-errors (SE) and P values as well-as probabilities of binary phenotypes were calculated using "emmeans" Package in R (https://cran.r-project.org/web/packages/emmeans/emmeans.pdf).

Ethics:

The study was approved by the Ethics Committees at Sagamie Hospital in Chicoutimi, the CHUM in Montréal and the Hospital for Sick Children in Toronto.

Age, blood pressure (BP), selected anthropomorphic phenotypes, smoking habits are compared, separately for males and females, in Table S1 (Supplementary material). Table 1 shows the impact of risk allele (T) of SNP rs2074192 as being more significantly associated with several features of hypertension in males compared to females as well as specific features of obesity (such as subscapular skinfold) which we have previously described as having higher genetic determinants. 19 A c c e p t e d M a n u s c r i p t Figure 1 shows that T allelic frequencies were similar in males (37%) and females (33%, p=0.2), and that the association between SNP rs2074192 and hypertension was significant in both males and females (p=0.03 and p=0.04, respectively).

To assess whether the association between genotypes and blood pressure phenotypes was modified by obesity, we selected normotensive and hypertensive individuals who were not taking anti-hypertensive medication and divided them into obese (BMI ≥28, obesity threshold used previously 19 ) and non-obese sub-groups, in the two sexes separately. Blood pressure differed significantly between genotypes only among obese individuals of both sexes, with no difference among non-obese individuals ( We then compared the ACE2 genotype frequencies in male subgroups. Figure 2A shows that T genotype represents a significant risk for hypertension in obese OR=1.4 (95% CI: 1.1-1.8) and more so in obese males who smoke (OR=1.7, 95% CI: 1.

showed that the T genotype predisposes to earlier onset of hypertension among obese and obese, smoking males ( Figure 2B ). For example, at age of 45 years, over 50% of obese and smoking males with genotype T have hypertension compared with only 10% of genotype C carriers. Figure S3A shows that the T genotype tends to be more frequent among hypertensive males taking anti-hypertensive medications (as a sign of hypertension severity and past outcome A c c e p t e d M a n u s c r i p t events) than among those not taking any. Similarly, a higher T/T genotype frequency was observed among females taking 2 or more antihypertensive medications to control their blood pressure. In addition, in the group of subjects with no contraindication to withdraw medication, there was an under-representation of the risk allele T ( Figure S3B) . The difference was significant in females (p=0.002).

The characteristics of the adolescent sample is presented in Table S2 . In adolescents, the ACE2 genotype at rs233575 (A/G) was associated with SBP and DBP in interaction with overweight/obesity and sex ( Figure S4 ). This 3-way interaction was nearly significant for SBP (p=0.09) and significant for DBP: p=0.04). For both SBP and DBP, the interaction was due to the A allele being associated with higher blood pressure mainly in overweight/obese females; in these females, AA vs. GG genotype was associated with higher SBP by 8 mmHg (p=0.005) and

higher DBP by 10 mmHg (p=0.003; Figure S4 ).

We used 12 SNPs spanning ACE2 gene ( Figure S5 ) to assess further the relationship between ACE2 and hypertension in relation to age, sex, obesity and smoking in the British participants of the UK Biobank. Table 3 (Table S3) .

Age and BMI were the two notable differences between British individuals who tested negative or positive to COVID-19 infection in both sexes (Table S4 ). Among the positive individuals, 56% of males had severe outcomes compared to 47% of females ( Figure 4 ). Males who had severe outcomes requiring hospitalization were generally older (p = 1.4 x 10 -9 ) than those with mild outcomes, who did not require hospitalisation. Comparison of infected males who had severe vs mild outcomes showed significant clinical differences including higher % of individuals with hypertension, diabetes, albuminuria and low eGFR ( Figure 4) . Furthermore, individuals who had mild symptoms to COVID-19 were significantly younger, had less:

hypertension, diabetes, declining renal function compared to people testing negative to COVID-19. Noticeably, SNP rs2074192 was nominally significantly associated (OR = 4.07; p = 0.036) with more severe outcomes of COVID-19 within obese smoking males of 50 years or older ( Figure 3B ). The association remained the same after adjustment for hypertension.

In the FC population, we have demonstrated distinct genomic architecture between hypertensive families with and without obesity, and this feature persists in the depth of 26 generations. 30 The ACE2 genotype represents a significant risk for hypertension particularly in obese males who smoke in whom the T genotype of rs2074192 predisposes to earlier onset of hypertension among obese and obese, smoking males ( Figure 2B) . individuals and after inflammatory cytokine treatment. 33 We examined the genomic context of SNPs rs233575 and rs2074192 with ENCODE 26 , GTEx 27

and HaploReg v4.1. 28 Both SNPs are located in intron 16 within a regulatory element characterized by high H3K27Ac signal (indicates regulatory-factor binding 34 , Figure S1A ). Both

SNPs alter binding of regulatory factors, including ARID5A which is an RNA-binding protein that plays a key a role in posttranscriptional events, such as splicing, and is stimulated by inflammation ( Figure S2 ). 35 Of note, exon 17 of ACE2 is expressed at a substantially lower level than its neighboring exons 16 and 18 in tissues with high expression of ACE2 (e.g. testes, kidney, heart and adipose tissue; Figure S1B ). Whether the intronic region of ACE2 tagged by our 2

SNPs is involved in the regulation of alternative splicing, i.e., the generation of transcripts without exon 17, requires further exploration.

Our data suggest that the ACE2 locus has an impact on hypertension in obese individuals rather than on obesity itself (Tables 2 and 3 ). Genotype T hypertensive males have higher mean values of anthropomorphic measures related with fat and its distribution than genotype C A c c e p t e d M a n u s c r i p t carriers, while among normotensives the association shows an opposite tendency. Such a tendency of opposite association in hypertensive versus normotensive males indicates that once genotype T male carriers gain weight, they develop hypertension. A higher hypertension risk among obese, male smokers with T genotype is consistent with our study hypothesis that individuals with the T allele lose the protective effect of the C allele against hypertension and are therefore more likely to develop hypertension when risk factors, such as obesity and smoking, are present. They could be also more at risk of developing severe outcomes after COVID-19

infection at older age.

The impact of smoking on hypertension was previously demonstrated in the context of genetic variation in ACE1. The interaction of ACE1 with smoking, similar to the ACE2-smoking interaction found in this study, can be explained by the fact that both RAAS components (if not in imbalance) and smoking increase the degradation of nitric oxide and the production of free radicals, causing endothelial damage and impaired vasodilatation. We have previously shown that smoking can interact with genetic determinants of certain stroke types. 36 We have also reported, in the same population studied here, a cluster encompassing genes associated to hypertension, obesity, smoking and response to stress, jointly driven by neuronal plasticity genes in a sex-specific matter. 37 Specific mechanism of association with ACE2 polymorphism, hypertension and smoking requires further exploration.

A stronger impact of the ACE2-obesity-smoking interaction in hypertensive males compared to females may be attributed to different causes. One could be the ACE2 localization on chromosome X. It is known that the female X chromosomes undergoes inactivation which is not always random, some regions remain transcriptionally active to a certain level, thus leaving 2 active alleles in females compared to only 1 in males. The involvement of chromosome X in A c c e p t e d M a n u s c r i p t hypertension is also supported by the fact that about 50% of Turner syndrome females present with cardiovascular outcomes. 38 The same argument can be made for the susceptibility to severe COVID-19 outcomes. In UK Biobank, 56% of males had severe outcomes to COVID-19 while 54% of females had mild outcomes ( Figure 4 ). Noticeably individuals with mild outcomes seemed to have better renal function compatible with recent findings of COVID-19 related dysfunction of proximal tubule. 39

The M a n u s c r i p t Analysis restricted to participants in whom anti-HT medication was withdrawn.

* and NS indicate whether the difference in mean BP between the 2 genotypes is statistically significant at α = 0.05 ( * ) or non-significant ( NS ).

DBP, diastolic blood pressure; MAP, mean arterial pressure; PP, pulse pressure; SBP, systolic blood pressure.

A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t 

Articles Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Gender differences in patients with COVID-19: Focus on severity and mortality

The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: A systematic review and meta-analysis

Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease

Hospitalized With COVID-19 in the New York City Area

Angiotensin-converting enzyme 2 is an essential regulator of heart function

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

Hypertension and hypertensive left ventricular hypertrophy are associated with ACE2 genetic polymorphism

The Association Between ACE2 Gene Polymorphism and the Stroke Recurrence in Chinese Population

ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus

Association of polymorphisms of angiotensin I converting enzyme 2 with retinopathy in type 2 diabetes mellitus among Chinese individuals

Chromosomal mapping of two genetic loci associated with blood-pressure regulation in rats

Role of Chromosome X in the Sabra Rat Model of Salt-Sensitive Hypertension

The association between the angiotensin-converting enzyme-2 gene and blood pressure in a cohort study of adolescents

Hypertension and COVID-19

The Role of Host Genetic Factors in Coronavirus Susceptibility: Review of Animal and Systematic Review of Human Literature

Population history and its impact on medical genetics in Quebec

Linkage Disequilibrium Analysis in Young Populations: Pseudo-Vitamin D-Deficiency Rickets and the Founder Effect in French Canadians

Quantitative Founder-Effect Analysis of French Canadian Families Identifies Specific Loci Contributing to Metabolic Phenotypes of Hypertension

Predictors of Target Organ Damage in Hypertensive Blacks and Whites

Distribution of blood pressure and hypertension in Canada and the United States

The Saguenay Youth Study (SYS)

A self-report measure of pubertal status: Reliability, validity, and initial norms

The UK Biobank resource with deep phenotyping and genomic data

Systematic discovery and characterization of regulatory motifs in ENCODE TF binding experiments

HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants

Longitudinal data analysis using generalized linear models

Genome-wide scan for linkage to obesity-associated hypertension in French Canadians

ACE2 Deficiency Worsens Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Response to Diet-Induced Obesity

Protecting the Heart in Obesity: Role of ACE2 and Its Partners

Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation

Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome

Arid5a, an RNA-Binding Protein in Immune Regulation: RNA Stability, Inflammation, and Autoimmunity

Tobacco smoking strongly association of prothrombin G20210A with undetermined stroke: Consecutive survivors and population-based controls

Genetic mapping of habitual substance use, obesity-related traits, responses to mental and physical stress, and heart rate and blood pressure measurements reveals shared genes that are overrepresented in the neural synapse

Hypertension is a major risk factor for aortic root dilatation in women with Turner"s syndrome

-2 causes a specific dysfunction of the kidney proximal tubule

The authors wish to thank Malgorzata Labuda for the initial analyses of the French-Canadian families.

A c c e p t e d M a n u s c r i p t M a n u s c r i p t Obesity parameters TBF skinfold -%; Mean (SD) 26 A c c e p t e d M a n u s c r i p t ‡ Previous or current smokers; missing values for smoking: 51 males, 61 females.BMI, body mass index; DBP, diastolic blood pressure; HT medication, anti-hypertensive medication;MAP, mean arterial pressure; PP, pulse pressure; SBP, systolic blood pressure; TBF, total body fat.

A c c e p t e d M a n u s c r i p t